Building a Drug Development Machine

Through our integrated research and development program, we're focused on Accelerating Treatments to Patients. One of our key initiatives is drug development through drug repurposing, which involves working with our Scientific Advisory Committee, Drug Development Advisory Group, Contract Research Organizations and pharmaceutical and biotech partners to test existing compounds as potential therapies for PKD. The end goal is clear – advance promising compounds into clinical trials and discover approved therapies for patients.